BBVA USA Bancshares’s GSK GSK Stock Holding History

BBVA USA Bancshares’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,897	Closed	-$258K	–	536
2017 Q1	$258K	Sell	4,897 -72	-1%	-$3.65K	0.02%	489
2016 Q4	$239K	Sell	4,969 -476	-9%	-$23.5K	0.02%	501
2016 Q3	$294K	Buy	5,445 +548	+11%	+$30K	0.02%	461
2016 Q2	$265K	Sell	4,897 -185	-4%	-$9.75K	0.02%	462
2016 Q1	$258K	Sell	5,082 -612	-11%	-$30.5K	0.02%	458
2015 Q4	$287K	Buy	+5,694	New	+$290K	0.02%	422
2015 Q3	–	Sell	-166,157	Closed	-$8.65M	–	477
2015 Q2	$8.65M	Sell	166,157 -2,793	-2%	-$157K	0.48%	59
2015 Q1	$9.75M	Sell	168,950 -7,589	-4%	-$435K	0.44%	71
2014 Q4	$9.43M	Sell	176,539 -22,419	-11%	-$1.25M	0.43%	70
2014 Q3	$11.4M	Buy	198,958 +6,954	+4%	+$426K	0.51%	56
2014 Q2	$12.8M	Buy	192,004 +4,847	+3%	+$328K	0.56%	47
2014 Q1	$12.5M	Buy	187,157 +7,143	+4%	+$483K	0.57%	46
2013 Q4	$12M	Buy	180,014 +7,309	+4%	+$474K	0.52%	52
2013 Q3	$10.8M	Buy	172,705 +4,410	+3%	+$284K	0.52%	57
2013 Q2	$10.5M	Buy	+168,295	New	+$10.7M	0.53%	56

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BBVA USA Bancshares's GSK Position: Q2 2017 in Review

BBVA USA Bancshares sold out of GSK (GSK) in Q2 2017, closing a stake of 4,897 shares — an estimated $258K sold.

BBVA USA Bancshares first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $12.8M in Q2 2014. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

BBVA USA Bancshares reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
BBVA USA Bancshares sold 4,897 GSK shares in Q2 2017, an estimated $258K.
BBVA USA Bancshares first reported a position in GSK in Q2 2013 and held it in 15 quarters.
BBVA USA Bancshares's GSK position peaked at $12.8M in Q2 2014.
779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on BBVA USA Bancshares's 13F filing for Q2 2017, filed 27 Jul 2017.